|
WO2006044263A2
|
|
Treatment of herpes
|
|
US2006194212A1
|
|
Treatment of AIDS
|
|
US2005152902A1
|
|
Treatment of diabetic retinopathy
|
|
US2005276807A1
|
|
Treatment of acne
|
|
US2005276806A1
|
|
Treatment of autism
|
|
AU2003297570A1
|
|
Treatment of skin diseases
|
|
AU2003272553A8
|
|
Treatment of schizophrenia
|
|
US2004062768A1
|
|
Compositions and methods for treating hyperimmune response in the eye
|
|
US2004086508A1
|
|
Treatment of organ transplant rejection
|
|
US2004052790A1
|
|
Treatment of schizophrenia
|
|
US2003215448A1
|
|
Compositions and methods for treating hyperimmune response in the eye
|
|
AU2003222250A1
|
|
Treatment of autoimmune diseases
|
|
US2003228310A1
|
|
Treatment of skin diseases
|
|
US2003223995A1
|
|
Treatment of pemphigus vulgaris
|
|
US2003086925A1
|
|
Treatment of autoimmune diseases
|
|
US2002182212A1
|
|
Compositions and methods for treating hyperimmune response in the eye
|
|
AU4321901A
|
|
Methods of prevention and treatment of asthma, and allergic conditions
|
|
US6863890B1
|
|
Treatment of AIDS with antibodies to gamma interferon, alpha interferon and TNF-alpha
|
